Jay Kailash Namkeen Ltd vs Sampre Nutritions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 30, 2026

Key Highlights

The Latest Trading Price of Jay Kailash Namkeen Ltd is ₹ 58.68 as of 30 Sep 15:30 . The P/E Ratio of Jay Kailash Namkeen Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Sampre Nutritions Ltd changed from 178.9 on March 2023 to 54.1 on March 2026 . This represents a CAGR of -25.84% over 4 years The Market Cap of Jay Kailash Namkeen Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Sampre Nutritions Ltd changed from ₹ 62.7 crore on March 2023 to ₹ 164.46 crore on March 2026 . This represents a CAGR of 27.26% over 4 years The revenue of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sampre Nutritions Ltd for the Jun '26 is ₹ 14.92 crore as compare to the Mar '26 revenue of ₹ 15.77 crore. This represent the decline of -5.39% The ebitda of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sampre Nutritions Ltd for the Jun '26 is ₹ 1.57 crore as compare to the Mar '26 ebitda of ₹ 1.1 crore. This represent the growth of 42.73% The net profit of Jay Kailash Namkeen Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sampre Nutritions Ltd changed from ₹ 0.1 crore to ₹ 0.7 crore over 9 quarters. This represents a CAGR of 137.46% The Dividend Payout of Jay Kailash Namkeen Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sampre Nutritions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Jay Kailash Namkeen Ltd

Jay Kailash Namkeen Limited was originally incorporated on June 30, 2021 as 'Jay Kailash Namkeen (OPC) Private Limited' with the RoC.
Subsequently, Company had acquired the ongoing business of Proprietorship Firm, 'M/s.
Kailash Namkeen' via Business Transfer Agreement dated July 26, 2021, which changed the name of the Company to 'Jay Kailash Namkeen Private Limited' on May 25, 2022.
Finally, the status was converted into Public Company as 'Jay Kailash Namkeen Limited' vide fresh Certificate of Incorporation dated June 24, 2022 issued by the Registrar of Companies, Ahmedabad. Prior to incorporation of the Company, 'M/s.
Kailash Namkeen', a Proprietorship Firm, was founded by Nishitbhai Navinbhai Sonchhatra, which engaged in the business of manufacturing Namkeen in Rajkot, Gujarat.

About Sampre Nutritions Ltd

Sampre Nutritions Limited., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh.
The Company is into the activity of manufacturing of Sugar Candies.
The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996.
In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'. During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'. The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka. During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.

FAQs for the comparison of Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd

Which company has a larger market capitalization, Jay Kailash Namkeen Ltd or Sampre Nutritions Ltd?

Market cap of Jay Kailash Namkeen Ltd is 29 Cr while Market cap of Sampre Nutritions Ltd is 58 Cr

What are the key factors driving the stock performance of Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd?

The stock performance of Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd?

As of September 30, 2026, the Jay Kailash Namkeen Ltd stock price is INR ₹58.68. On the other hand, Sampre Nutritions Ltd stock price is INR ₹6.13.

How do dividend payouts of Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd compare?

To compare the dividend payouts of Jay Kailash Namkeen Ltd and Sampre Nutritions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.